Mimura Y, Ogura T, Kataoka H, Oishi T, Asano N, Kishida M, Yamauchi T, Ogawa N, Makino H
Third Department of Internal Medicine, Okayama University, Japan.
Res Commun Mol Pathol Pharmacol. 1997 Jan;95(1):43-56.
We previously examined the precise localization of vasopressin (VP) V1 and V2 receptors in the rat kidney using in vitro macro- and micro-autoradiography (ARG), and established the methodology of quantification for macro-ARG. In this study, to elucidate the role of VP in hypertension, we investigated the change within V1 and V2 receptors in the kidney of spontaneously hypertensive rats (SHR) and deoxycorticosterone acetate (DOCA)-salt hypertensive rats at different hypertensive stages. In SHR, although medullary V1 and V2 receptors decreased compared with age-matched Wistar-Kyoto (WKY) rats at the developmental hypertensive stage, these receptors increased once hypertension was established. Conversely, in DOCA-salt hypertensive rats, both renal V1 and V2 receptors decreased with elevated blood pressure. Therefore, expression of renal V1 and V2 receptors proved to be different between two models of hypertension, SHR and DOCA-salt hypertensive rats, when their blood pressure increases. In DOCA-salt hypertensive rats, renal V1 and V2 receptors may be down-regulated secondary to the high blood VP level. In SHR, the increase in renal V1 and V2 receptors may have a role in the development of high blood pressure in this strain of rats.
我们之前利用体外宏观和微观放射自显影术(ARG)研究了大鼠肾脏中血管加压素(VP)V1和V2受体的精确定位,并建立了宏观ARG的定量方法。在本研究中,为了阐明VP在高血压中的作用,我们调查了自发性高血压大鼠(SHR)和醋酸脱氧皮质酮(DOCA)-盐性高血压大鼠在不同高血压阶段肾脏中V1和V2受体的变化。在SHR中,虽然在发育性高血压阶段,与年龄匹配的Wistar-Kyoto(WKY)大鼠相比,髓质V1和V2受体减少,但一旦高血压形成,这些受体就会增加。相反,在DOCA-盐性高血压大鼠中,随着血压升高,肾脏V1和V2受体均减少。因此,当血压升高时,SHR和DOCA-盐性高血压大鼠这两种高血压模型中肾脏V1和V2受体的表达被证明是不同的。在DOCA-盐性高血压大鼠中,肾脏V1和V2受体可能因高血VP水平而被下调。在SHR中,肾脏V1和V2受体的增加可能在该品系大鼠高血压的发生中起作用。